Collectively, these data suggest that theophylline has an anti-fibrotic effect on BLM-induced pulmonary fibrosis by inhibiting the TGF-β/Akt/Smad2/3 pathway. This evidence concerns the gene TGFB1 and pulmonary fibrosis.